Literature DB >> 15529154

How similar do 'biosimilars' need to be?

Huub Schellekens1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15529154     DOI： 10.1038/nbt1104-1357

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  18 in total

Review 1.  Through the looking glass: the protein science of biosimilars.

Authors:  David Goldsmith; Martin Kuhlmann; Adrian Covic
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

2.  Biosimilars in 3D: definition, development and differentiation.

Authors:  Ivo Abraham; Diana Sun; Alaa Bagalagel; Ahmed Altyar; Abdulaziz Mohammed; Soba Tharmarajah; Karen MacDonald
Journal:  Bioengineered       Date:  2013-05-16       Impact factor: 3.269

Review 3.  Pharmacovigilance of biopharmaceuticals: challenges remain.

Authors:  Thijs J Giezen; Aukje K Mantel-Teeuwisse; Hubert G M Leufkens
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Statistical Considerations in the Design of Biosimilar Cancer Clinical Trials.

Authors:  Chul Ahn; Seung-Chun Lee
Journal:  Ungyong Tonggye Yongu       Date:  2011-06-01

5.  Unified superresolution experiments and stochastic theory provide mechanistic insight into protein ion-exchange adsorptive separations.

Authors:  Lydia Kisley; Jixin Chen; Andrea P Mansur; Bo Shuang; Katerina Kourentzi; Mohan-Vivekanandan Poongavanam; Wen-Hsiang Chen; Sagar Dhamane; Richard C Willson; Christy F Landes
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-23       Impact factor: 11.205

6.  Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.

Authors:  Neh Nupur; Nidhi Chhabra; Rozaleen Dash; Anurag S Rathore
Journal:  MAbs       Date:  2017-12-07       Impact factor: 5.857

7.  Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.

Authors:  Thijs J Giezen; Aukje K Mantel-Teeuwisse; Ronald H B Meyboom; Sabine M J M Straus; Hubert G M Leufkens; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-10-01       Impact factor: 5.606

Review 8.  Biosimilars: recent developments.

Authors:  A Covic; M K Kuhlmann
Journal:  Int Urol Nephrol       Date:  2007-02-27       Impact factor: 2.370

9.  Fish oil metabolites: translating promising findings from bench to bedside to reduce cardiovascular disease.

Authors:  P Calderon Artero; C Champagne; S Garigen; Sa Mousa; Rc Block
Journal:  J Glycomics Lipidomics       Date:  2012-02-27

10.  Current status of biosimilar growth hormone.

Authors:  Paul Saenger
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.